## Abstract Long term effect of the growing instability of the boneβimplant interface due to bone resorption at the interface is a problem for the implants, including bioactive ceramics. Zn^2+^βcontaining tricalcium phosphate (ZnTCP) is a material which may overcome this problem. The present study
Resorbability and solubility of zinc-containing tricalcium phosphate
β Scribed by Ito, Atsuo ;Kawamura, Haruo ;Miyakawa, Shunpei ;Layrolle, Pierre ;Kanzaki, Noriko ;Treboux, Gabin ;Onuma, Kazuo ;Tsutsumi, Sadao
- Book ID
- 102292508
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 202 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Using zincβcontaining tricalcium phosphate (ZnTCP) as the zinc carrier for zincβreleasing calcium phosphate ceramic implants promoted bone formation around the implants. Because no quantitative information was available on the equilibrium solubility and resorbability of ZnTCP, in vitro equilibrium solubility and in vivo resorbability of ZnTCP were determined and compared quantitatively in this study. The solubility of ZnTCP decreased with increasing zinc content. The negative logarithm of the solubility product (K~sp~) of ZnTCP was expressed as p__K__~sp~ = 28.686 + 1.7414__C__ β 0.42239__C__^2^ + 0.063911__C__^3^ β 0.0051037__C__^4^ + 0.0001595__C__^5^ in air, where C is the zinc content in ZnTCP (mol %). The solubility of ZnTCP containing a nontoxic level of zinc (<0.63 wt %) decreased to 52β92% of the solubility of pure tricalcium phosphate (TCP) in the pH range 5.0β7.4. However, the in vivo resorbed volume of ZnTCP containing the same amount of zinc was much lower than that expected from the in vitro solubility, becoming as low as 26β20% of that of TCP. Cellular resorption of TCP is substantially a process of dissolution in a fluid with an acidic pH that is maintained by the activities of cells. Therefore, the reduction of the resorbability of ZnTCP could be attributable principally to its lowered cellular activation property relative to that associated with pure TCP. Β© 2002 John Wiley & Sons, Inc. J Biomed Mater Res 60: 224β231, 2002; DOI 10.1002/jbm.10068
π SIMILAR VOLUMES
## Abstract Our previous studies have suggested that synthetic octacalcium phosphate (OCP) could be resorbed and replaced by newly formed bone if implanted in rat skull defects. We hypothesized that the implanted OCP is more resorbable than other commonly used bone graft substitutes of calcium phos
The equilibrium solubility of Mg-containing b-tricalcium phosphate (bMgTCP) with various magnesium contents was determined by immersing bMgTCP powder for 27 months in a CH 3 COOH-CH 3 COONa buffer solution at 25 Β°C under a nitrogen gas atmosphere. The negative logarithm of the solubility product (pK
The in vitro Zn release from tricalcium phosphate containing Zn (ZnTCP; 0.63, 6.17, and 12.05 Zn w/w%) was investigated. The rates of release from ZnTCP powders were measured in 25 mL of simulated body fluid (SBF) containing 10 mg/100mL Ca (SBF/H), 5 mg/100mL Ca (SBF/L), or no Ca (SBF/-) at pH 7.25,
Controlling the strength-loss rate during biodegradation is a bottleneck in developing viable resorbable ceramic implants. Resorbable betatricalcium phosphate (Ξ²-TCP) bioceramic is known for its excellent biocompatibility. However, it exhibits poor sinterability and poor flexural strength. Here, we